Related Experiment Videos

[Program for the collection of normal hematological data in Italy]

Haematologica Latina

|January 1, 1970

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Targeted therapy for brain tumours: role of PARP inhibitors.

Current cancer drug targets·2012

PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy.

Oncogene·2010

Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent.

Current cancer drug targets·2010

Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester.

Cell death and differentiation·2001

Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells.

Cell death and differentiation·2001

Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components.

Cancer chemotherapy and pharmacology·2001

See all related articles